Sabatini Brent
SVP, Chief Accounting Officer
Sabatini Brent has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jun 2, 2026.
On the most recent filing, Sabatini Brent is listed as SVP, Chief Accounting Officer at Vir Biotechnology, Inc. Inside the rolling window, Sabatini Brent reported no open-market purchases and 5 open-market sales totaling $113K in VIR. The largest disclosed transaction in the window is a sale of 7,711 VIR shares on Mar 23, 2026, worth $70K.
Companies traded
Other insiders at VIR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$113K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sabatini Brent made?
Sabatini Brent has filed 5 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does Sabatini Brent trade?
Sabatini Brent has filed SEC Form 4 disclosures for 1 company, including VIR.
When was Sabatini Brent's most recent SEC Form 4 filing?
Sabatini Brent's most recent SEC Form 4 filing on Tracefour is dated Jun 2, 2026.
What is Sabatini Brent's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sabatini Brent is listed as SVP, Chief Accounting Officer.
What is Sabatini Brent's total buy and sell value in the current window?
Inside the rolling retention window, Sabatini Brent bought $0 and sold $113K based on SEC Form 4 filings.
What was Sabatini Brent's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,711 VIR shares on 2026-03-23, worth $70K, per SEC Form 4 filings.